Evogene Ltd.

For the period ended Oct 6, 2026. Filed Oct 6, 2026.

About this filing

What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.

Oct 6, 2026 · Filed Oct 6, 2026

Use the contents to explore the available documents and sections.

EVGN$0.27-17.8%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

EX-99.2 · Form of Proxy Statement

Form of Proxy Statement

A -11

EXHIBIT B

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.